Related Experiment Video
Updated: May 10, 2026
10:41
Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
Primary and secondary dystonic syndromes: an update
Gavin Charlesworth1, Kailash P Bhatia
1Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK.
Current Opinion in Neurology
|June 13, 2013
Summary
Recent discoveries have identified new genes and subtypes of dystonia, improving our understanding of its causes and leading to better diagnosis and treatment. Further research into the extramotor phenotype and cerebellar involvement is ongoing.
Area of Science:
- Neuroscience
- Genetics
- Neurology
Background:
- Dystonias are common, complex neurological disorders with varied causes and presentations.
- Understanding the genetic basis and pathophysiology of dystonia is crucial for clinical practice.
Purpose of the Study:
- To review significant discoveries in dystonia research over the past 18 months.
- To highlight advancements in genetic causes, phenotypic variations, and pathophysiology.
Main Methods:
- Literature review of recent scientific publications on dystonia.
- Synthesis of findings related to genetic discoveries, new subtypes, and clinical presentations.
Main Results:
- Identification of five new genes associated with primary dystonia (PRRT2, CIZ1, ANO3, TUBB4A, GNAL).
- Delineation of new neuronal brain iron accumulation subtypes linked to C19orf12 and WDR45 mutations.
- Description of a treatable dystonia form with manganese deposition due to SLC30A10 mutations.
- Expansion of known phenotypes and recognition of the extramotor phenotype and cerebellar role in dystonia.
Conclusions:
- Recent genetic and phenotypic discoveries are transforming the understanding of dystonic syndromes.
- Improved diagnosis and treatment are anticipated due to a better grasp of genetic causes and phenotypic variability.
- These advancements hold promise for future progress in elucidating dystonia's underlying pathophysiology.
Related Concept Videos
01:12Alterations in Muscle Tone ll
Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
01:25Secondary Spinal Cord Injury llI: Pathophysiology
Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:28Disorders of the Skeletal Muscle
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...